Email Updates
Study
Risk factors for adverse events in patients with breast, colorectal, and lung cancer.
May 23, 2018
Weingart SN, Atoria CL, Pfister D, et al. J Patient Saf. 2021;17(8):e701-e707.
This retrospective cohort study identified frequent treatment-related adverse events for patients with breast, colorectal, or lung cancer, with 34% of patients experiencing an adverse event during their treatment course. Advanced disease and chemotherapy conferred higher risk for adverse events, as did non-White race and Hispanic ethnicity. The authors suggest that such factors could be used for prospective identification of patients at highest risk for adverse events.
Related Resources From the Same Author(s)
Related Resources
See More About The Topic
